ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Androgen Society 3rd Annual Meeting Review (Day 3)
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 201962" data-attributes="member: 13851"><p><h2>Androgen Society 3rd Annual Meeting Review (Day 3) –</h2><h2>Summary:</h2><p><strong><em>Abraham Morgentaler, MD, FACS, Associate Clinical Professor of Urologic Surgery at Harvard University, reviews day three of the 3rd annual meeting of the Androgen Society, an international organization consisting of healthcare professionals interested in testosterone deficiency and its treatment. </em></strong><em>The day began when Martin Miner, MD, and Jean-Paul Deslypere, MD, Ph.D., debated the correct threshold for diagnosing testosterone deficiency, ultimately concluding that the lower the T level, the better. Dr. Desylpere then discussed the role of active metabolites of testosterone in manhood, specifically the importance of testosterone in developing structural and functional characteristics of the sex. Hugh Jones, MD, followed with an analysis of androgen receptor sensitivity and its implications for clinical disorders and mortality. Abdulmaged Traish, Ph.D., then presented on whether or not age-related testosterone deficiency should be treated, respectfully disagreeing with the FDA’s position on not treating men with age-related hypogonadism. Martin Miner, MD, then looked at the relationship between testosterone and mood, depression, and dementia. Next, David Sullivan, MS, Ph.D., shared information about the preventative effect of androgens on dry eyes. Ernani Rhoden, MD, spoke on testosterone and gynecomastia before engaging in a debate on whether testosterone therapy may be used as a monotherapy treatment of erectile dysfunction. The day concluded with a discussion by Dr. Morgentaler on testosterone, science, and human dignity that stemmed from his experiences with patients wanting testosterone therapy despite the impact on their life expectancies out of a desire to improve their quality of life.</em></p><p><em></em></p><p><em>A summary of day one of the meeting can be watched <strong><a href="https://grandroundsinurology.com/androgen-society-3rd-annual-meeting-review-day-1/" target="_blank">here</a></strong>. while day two is available <strong><a href="https://grandroundsinurology.com/androgen-society-3rd-annual-meeting-review-day-2/" target="_blank">here</a></strong>. For more on ADT, visit our <strong><a href="https://grandroundsinurology.com/next-generation-androgen-deprivation-therapy/" target="_blank">Next Generation Androgen Deprivation Therapy Learning Center</a></strong>.</em></p><p><em></em></p><p><em>[URL unfurl="true"]https://grandroundsinurology.com/androgen-society-3rd-annual-meeting-review-day-3/?utm_campaign=Weekly%20Email%20GRU&utm_content=168743693&utm_medium=social&utm_source=twitter&hss_channel=tw-4825344058[/URL]</em></p><p></p><p></p><p>[ATTACH=full]14549[/ATTACH]</p><p>[ATTACH=full]14550[/ATTACH]</p></blockquote><p></p>
[QUOTE="madman, post: 201962, member: 13851"] [HEADING=1]Androgen Society 3rd Annual Meeting Review (Day 3) –[/HEADING] [HEADING=1]Summary:[/HEADING] [B][I]Abraham Morgentaler, MD, FACS, Associate Clinical Professor of Urologic Surgery at Harvard University, reviews day three of the 3rd annual meeting of the Androgen Society, an international organization consisting of healthcare professionals interested in testosterone deficiency and its treatment. [/I][/B][I]The day began when Martin Miner, MD, and Jean-Paul Deslypere, MD, Ph.D., debated the correct threshold for diagnosing testosterone deficiency, ultimately concluding that the lower the T level, the better. Dr. Desylpere then discussed the role of active metabolites of testosterone in manhood, specifically the importance of testosterone in developing structural and functional characteristics of the sex. Hugh Jones, MD, followed with an analysis of androgen receptor sensitivity and its implications for clinical disorders and mortality. Abdulmaged Traish, Ph.D., then presented on whether or not age-related testosterone deficiency should be treated, respectfully disagreeing with the FDA’s position on not treating men with age-related hypogonadism. Martin Miner, MD, then looked at the relationship between testosterone and mood, depression, and dementia. Next, David Sullivan, MS, Ph.D., shared information about the preventative effect of androgens on dry eyes. Ernani Rhoden, MD, spoke on testosterone and gynecomastia before engaging in a debate on whether testosterone therapy may be used as a monotherapy treatment of erectile dysfunction. The day concluded with a discussion by Dr. Morgentaler on testosterone, science, and human dignity that stemmed from his experiences with patients wanting testosterone therapy despite the impact on their life expectancies out of a desire to improve their quality of life. A summary of day one of the meeting can be watched [B][URL='https://grandroundsinurology.com/androgen-society-3rd-annual-meeting-review-day-1/']here[/URL][/B]. while day two is available [B][URL='https://grandroundsinurology.com/androgen-society-3rd-annual-meeting-review-day-2/']here[/URL][/B]. For more on ADT, visit our [B][URL='https://grandroundsinurology.com/next-generation-androgen-deprivation-therapy/']Next Generation Androgen Deprivation Therapy Learning Center[/URL][/B]. [URL unfurl="true"]https://grandroundsinurology.com/androgen-society-3rd-annual-meeting-review-day-3/?utm_campaign=Weekly%20Email%20GRU&utm_content=168743693&utm_medium=social&utm_source=twitter&hss_channel=tw-4825344058[/URL][/I] [ATTACH type="full" alt="Screenshot (4948).png"]14549[/ATTACH] [ATTACH type="full" alt="Screenshot (4949).png"]14550[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Androgen Society 3rd Annual Meeting Review (Day 3)
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top